Search Results 341-350 of 17107 for nivolumab
... Nivolumab in Patients with Previously Treated Advanced Differentiated Thyroid Cancer". J Clin Endocrinol Metab 2025 Jun 17; 110 (7):e2425-e2426. View PubMed ...
Neoadjuvant BMS-813160, nivolumab, gemcitabine and nab-paclitaxel for patients with pancreatic cancer. Clin Cancer Res. 2025 Mar 24 [Epub ahead of print]
... nivolumab, commercialized under the brand name Opdualag™ and approved for the treatment of melanoma in adults and children. The study is looking at several ...
... nivolumab in patients with solid tumors that have spread and/or cannot be removed by surgery. The following tumor types are included in this study: Non ...
To find and listen to archived shows, click here. Shanna Talks About “Brighter Tomorrows” for Children With Cancer · Nivolumab shows significant benefit for ...
... (nivolumab) treatment plus platinum doublet chemotherapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...
Nivolumab. Nivolumab + relatlimab. Pembrolizumab. Pertuzumab +/- trastuzumab. Trastuzumab +/- pertuzumab. Zoledronic Acid (Zometa). 3.17 Willingness to follow ...
Description. Brentuximab injection is used to treat Hodgkin lymphoma, systemic anaplastic large cell lymphoma (sALCL), and primary cutaneous anaplastic ...
... Nivolumab Scottsdale/Phoenix, AZ; Rochester, MN ... The purpose of this study is to evaluate the dose escalation and expansion of RP1 alone and combined with ...
... Nivolumab + Ipilimumab in participants with unresectable pleural mesothelioma. Participation eligibility. Participant eligibility includes age, gender, type ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!